BioSpin's Innovations to Support Bruker Shares, Macro Issues to Ail
The newly acquired ELITech Molecular Diagnostics business also contributed, positioning Bruker as an emerging infectious disease specialist in the in-vitro diagnostics (IVD) market. Within Bruker’s ...
Yahoo Finance5d
BioSpin's Innovations to Support Bruker Shares, Macro Issues to Ail
Bruker’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and ongoing portfolio transformation. Yet, the company’s operations face the wrath of excessive ...
FY2025 Earnings Forecast for Bruker Issued By Zacks Research
Equities researchers at Zacks Research lifted their FY2025 earnings per share estimates for shares of Bruker in a research ...
Yahoo Finance25d
3 US Stocks That May Be Trading Below Their Estimated Value
Bruker Biospin at $905.70 million, and Bruker Energy & Supercon Technologies (BEST) at $283 million. Estimated Discount To Fair Value: 17.3% Bruker is trading at US$52.92, below its estimated fair ...
Bruker Co. (NASDAQ:BRKR) Receives $70.50 Consensus Target Price from Analysts
Bruker Co. (NASDAQ:BRKR – Get Free Report) has received a consensus rating of “Moderate Buy” from the eleven analysts that are presently covering the company, Marketbeat Ratings reports. Five research ...
News Medical20d
Bruker Biospin's Fragment-based Screening with NMR
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...